Cargando…
Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation
Pancreatic ductal adenocarcinoma (PDAC) is virtually therapy-resistant. As noninvasive lesions progress to malignancy, the precursor period provides a window for cancer therapies that can interfere with neoplastic progression. Thymoquinone (Tq), a major bioactive component of essential oil from Nige...
Autores principales: | Relles, Daniel, Chipitsyna, Galina I., Gong, Qiaoke, Yeo, Charles J., Arafat, Hwyda A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220391/ https://www.ncbi.nlm.nih.gov/pubmed/28105374 http://dx.doi.org/10.1155/2016/1407840 |
Ejemplares similares
-
Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011) -
Histone acetylation and deacetylation in ischemic stroke
por: Uzdensky, Anatoly B., et al.
Publicado: (2021) -
Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer
por: Wang, Xiaorui, et al.
Publicado: (2023) -
Histone deacetylation: Establishing a meiotic histone code
por: De La Fuente, Rabindranath
Publicado: (2014) -
Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion—Preliminary Observations
por: Sarosiek, Konrad, et al.
Publicado: (2016)